kollaGen II-xs
Clinical Trial conducted by Morton Scientific Group, Cambridge, Ontario, Canada

The study also showed a normalizing of saliva pH levels which is often indicative of a reduction in inflammation.

The study results showed that KollaGen II-xs™ taken at a dosage of 375mg – 500mg twice a day appears to provide soothing properties to the joints, secondary mobility and other tertiary effects.

Clinical data adopted from Certified Nutraceuticals Inc.

Shopping cart0
There are no products in the cart!
Continue shopping